ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,513Medicare Part D Prescriptions Filled, Including Refills

Rank: 120 out of 337

$595K Total Retail Price of All Prescriptions

Rank: 48 out of 337

318 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 318 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 318 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 5,131 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
OMEPRAZOLE 296 215 1 4
ATORVASTATIN CALCIUM 252 194 2 7
FUROSEMIDE 216 160 3 8
AMLODIPINE BESYLATE 216 184 3 3
LEVOTHYROXINE SODIUM 198 186 5 5
PANTOPRAZOLE SODIUM 180 134 6 36
HYDROCODONE-ACETAMINOPHEN 174 85 S3 7 13
LISINOPRIL 171 137 8 2
WARFARIN SODIUM 157 156 9 11
SIMVASTATIN 153 110 10 1
METOPROLOL TARTRATE 147 95 11 6
FENOFIBRATE 141 70 12 48
PRAVASTATIN SODIUM 137 91 13 14
SPIRONOLACTONE 116 80 14 100
GABAPENTIN 111 75 15 20
METFORMIN HCL 108 45 16 12
CRESTOR 103 66 17 29
OXYCODONE HCL 96 29 S2 18 63
TAMSULOSIN HCL 96 82 18 25
CITALOPRAM HBR 90 79 20 17
ALLOPURINOL 89 72 21 28
LOSARTAN POTASSIUM 87 67 22 15
BYSTOLIC 86 39 23 91
OXYCODONE HCL-ACETAMINOPHEN 70 0 S2 24 152
GLIMEPIRIDE 69 37 25 55
NEXIUM 69 23 25 56
SERTRALINE HCL 65 44 27 18
ZOLPIDEM TARTRATE 65 26 27 23
DIOVAN 62 50 29 26
LOVASTATIN 56 55 30 24
ZETIA 56 41 30 89
FINASTERIDE 55 52 32 83
TRAMADOL HCL 55 43 32 32
TRAZODONE HCL 54 48 34 16
LIPITOR 53 51 35 33
LANTUS 52 24 36 49
BENICAR 52 37 36 110
HYDROCHLOROTHIAZIDE 51 47 38 9
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.